SPOTLIGHT -
News
Article
Author(s):
Brush up on your reading before you attend the Southern California Psychiatry Conference!
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Positive Phase 2b/3 Open-Label Extension Trial Results: Blarcamesine for Treatment of Early Alzheimer Disease
New Data: Zervimesine for the Treatment of Dementia With Lewy Bodies and Alzheimer Disease
New Insights on Alzheimer Disease Treatments and Diagnostic Tools: Trontinemab and the Elecsys pTau217
Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
Exploring NMDA Antagonists for MDD